Over 15 million people participated in racial justice protests nationwide during 2020-2021 spotlighting activism as a collective tool against structural racism and discrimination (SRD). SRD manifests as policies and practices (e.g., redlining, voter suppression, mass incarceration) that produce hostile environments that contribute to psychological distress, elevated allostatic load, and an elevated risk for chronic diseases and premature death, concentrated within Black and Latinx populations. While the connection between SRD and health is well documented, few studies provide evidence on strategies to reduce SRD and mitigate consequences on psychological and physiological outcomes. Thus, there is a critical need to rigorously test interventions that improve the mental and physical health of Black and Latinx populations, beginning in adolescence. The study's specific aims are to 1) Determine whether a racial justice activism behavioral intervention prevents and reduces depressive symptoms in Black and Latinx adolescents and young adults and 2) Determine whether a racial justice activism behavioral intervention lowers allostatic load scores in Black and Latinx adolescents and young adults. To accomplish these aims, the team will conduct a stage II group-based, multi-component, and multilevel randomized behavioral clinical trial. The investigators will collect psychological and physiological measures at baseline, then at defined intervals for 2 years post the racial justice activism intervention.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Depressive Symptoms
Timeframe: at baseline and then 0-1-, 6-, 12-, 18-, and 24- months post initial 5 day-intervention
Metabolic Syndrome
Timeframe: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention
Blood Pressure
Timeframe: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention
Triglycerides
Timeframe: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention
High-density lipoprotein
Timeframe: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention
Glycosylated hemoglobin
Timeframe: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention
Glucose
Timeframe: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention
Insulin
Timeframe: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention
Waist Circumference
Timeframe: at baseline and then 6-, 12-, and 24- months post initial 5 day-intervention